Notice for thiotepa (Link Medical Products Pty Ltd)
Active ingredients
thiotepa
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Powder for injection/Solution for infusion
Indication
Thiotepa is indicated in combination with other chemotherapy medicinal products as conditioning treatment prior to Haematopoietic Progenitor Cell Transplantation (HPCT)
Therapeutic area
Oncocoloy